Labcorp Holdings Inc. (LH) - Earnings growth forecast for next year

Laboratory Corporation of America - graphic logo of issuer LH

Labcorp Holdings Inc. (LH) aims strategically to monetize physician habits through a steady stream of diagnostic tests. Net income per share expectations demonstrate progress in this direction, where the value 6.50 represents the current metric. Growth is hindered by deep integration into the healthcare environment and a reliance of margins on the scale effect of the laboratory network.

LH: Labcorp Holdings Net earnings per share growth forecast for next year 07/04/2022 - 11/15/2026

Metric breakdowns and analytics for Labcorp Holdings (LH)

- price and consensus price forecast:
Fundamental company valuation:LH, Laboratory Corporation of America
Core merchandise of Labcorp

To identify fundamental sector leaders, analysts evaluate the potential for profit generation over the coming period. This indicator measures the expected percentage change in earnings per share by aggregating expert forecasts on future profitability. For Labcorp Holdings Inc. (LH), this calculation is critical, as geopolitical instability and supply chain disruptions directly impact the cost of tests. This forward-looking assessment of net income dynamics serves as a gauge for the business's resilience.